Advanced Serial Plasma Exchange Arrives in Atlanta as Environmental Exposure Concerns Grow Across Metro Region

Physician-led protocols launch inside Cenegenics Atlanta as research continues to examine relationships between environmental exposures, inflammation, and chronic health conditions.

ATLANTA, GA — MDLifespan, a physician-led medical technology company and Public Benefit Corporation, today announced the launch of its Advanced Serial Therapeutic Plasma Exchange (TPE) protocols inside Cenegenics Atlanta, expanding access to physician-led Advanced TPE in Georgia.

The integration introduces MDLifespan’s multi-session Advanced Therapeutic Plasma Exchange protocols to the Atlanta market. The protocols are designed to support the evaluation and reduction of certain circulating substances while incorporating biomarker analysis and physician oversight.

The launch comes as scientific research continues to examine the potential health implications of environmental exposures, including persistent chemicals, air pollution, and other environmental contaminants.

Metro Atlanta is one of the largest metropolitan regions in the United States, with more than six million residents across a complex network of transportation corridors, industrial activity, and rapidly growing communities.

Environmental monitoring and public-health research have identified several exposure considerations relevant to the region, including:

• Ozone pollution
• Short-term particle pollution, including PM2.5
• Transportation-related air pollution
• Industrial chemical releases
• PFAS contamination in parts of Georgia
• Localized soil contamination, including areas with elevated lead levels

In 2025, Fulton and Henry counties received failing grades for ozone pollution, while several surrounding counties received lower grades related to ozone and particle pollution.

Atlanta’s role as a major transportation hub also makes air quality and transportation-related particulate emissions an important part of the region’s environmental-health conversation.

Research has associated exposure to fine particulate matter with respiratory and cardiovascular effects, while researchers continue to investigate its relationship with inflammation and other biological processes.

Environmental health researchers continue to investigate how persistent environmental contaminants interact with biological systems.

These contaminants can include PFAS, toxic metals, industrial chemicals, pesticides, microplastics, and other pollutants.

Research has explored potential relationships between environmental exposures and biological processes including:

• Systemic inflammation
• Oxidative stress
• Endothelial dysfunction
• Immune dysregulation
• Neurological stress pathways

These processes are being studied in connection with a range of chronic health conditions, including cardiovascular disease, metabolic disorders, neurodegenerative disease, autoimmune conditions, and certain cancers.

Because some environmental contaminants can persist in the environment and the human body for extended periods, researchers continue to study methods for measuring exposure and evaluating strategies that may reduce circulating levels of specific substances.

Advanced Serial Therapeutic Plasma Exchange is a physician-led, multi-session protocol built around Therapeutic Plasma Exchange, an established medical procedure that separates plasma from blood components before replacing the plasma.

TPE has historically been used in hospital and specialty-care settings for specific medical indications, including certain autoimmune and neurological conditions.

MDLifespan’s Advanced TPE protocols use a structured outpatient model that incorporates physician oversight, diagnostic testing, biomarker evaluation, and protocol-specific planning.

The Atlanta integration gives patients access to this physician-led approach within the Cenegenics clinical environment.

“Environmental exposure is becoming an increasingly important part of the health conversation across the country,” said Dr. Paul Savage, Founder and Chief Medical Officer of MDLifespan.

“Research is beginning to demonstrate how long-term toxin accumulation may contribute to biological stress and systemic inflammation that can increase the risk for chronic diseases including neurodegenerative disorders, cardiovascular disease, and cancer. Our Advanced Serial Plasma Exchange protocols are structured physician-supervised programs designed to support measurable reductions in circulating toxin burden while integrating advanced biomarker analysis.”

Through the Cenegenics Atlanta integration, patients can access:

• Multi-session physician-led Advanced Serial Therapeutic Plasma Exchange protocols
• Diagnostics focused on environmental toxin exposure
• Biomarker testing related to inflammation and toxin burden
• Structured clinical pathways designed to support reduction of inflammatory burden
• Ongoing physician oversight and laboratory monitoring

Each MDLifespan protocol begins with diagnostic testing designed to evaluate relevant toxin markers and other biomarkers. Where appropriate, this is followed by a series of plasma exchange sessions and subsequent laboratory monitoring.

Progress can then be evaluated through objective laboratory data and physician review.

The Cenegenics Atlanta collaboration reflects MDLifespan’s broader protocol-driven approach to Advanced TPE.

MDLifespan’s clinical model integrates:

• Precision biomarker analysis
• Environmental toxin assessment
• Serial Advanced TPE protocols
• Physician-directed care pathways
• Ongoing laboratory monitoring

Rather than positioning plasma exchange as a single intervention, MDLifespan uses a structured protocol model designed to support evaluation and monitoring over time.

This approach allows physicians to consider relevant laboratory data, environmental exposure information, patient history, and individual health goals when determining whether an Advanced TPE protocol is appropriate.

The Cenegenics Atlanta integration supports MDLifespan’s broader national expansion strategy, which focuses on partnering with established physician-led clinics across the United States.

The company’s expansion strategy centers on:

• Integrating into established performance and longevity medicine centers
• Delivering standardized Advanced Serial TPE protocols
• Expanding geographic access to physician-led Advanced TPE
• Supporting biomarker-informed clinical evaluation
• Building partnerships within established healthcare environments

As environmental exposure continues to receive attention in public-health research, MDLifespan is expanding access to Advanced Therapeutic Plasma Exchange in Atlanta as part of its physician-led approach to evaluating environmental toxin burden and inflammatory biomarkers.

Patients interested in learning more about Advanced TPE in Atlanta can explore MDLifespan’s Advanced TPE resources or schedule a consultation HERE

Originally published via our press platform and republished in our official newsroom.